These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24157731)

  • 1. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
    Reglinski M; Sriskandan S
    Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project.
    Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M
    J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group A Streptococcus virulence and host factors in two toddlers with rheumatic fever following toxic shock syndrome.
    Smeesters PR; Drèze PA; Perez-Morga D; Biarent D; Van Melderen L; Vergison A
    Int J Infect Dis; 2010 May; 14(5):e403-9. PubMed ID: 19828348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome.
    Emgård J; Bergsten H; McCormick JK; Barrantes I; Skrede S; Sandberg JK; Norrby-Teglund A
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25923-25931. PubMed ID: 31772015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
    Ramachandran G; Tulapurkar ME; Harris KM; Arad G; Shirvan A; Shemesh R; Detolla LJ; Benazzi C; Opal SM; Kaempfer R; Cross AS
    J Infect Dis; 2013 Jun; 207(12):1869-77. PubMed ID: 23493729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive infection caused Streptococcus group A and streptococcal toxic shock syndrome].
    Danilova TA
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):99-105. PubMed ID: 11550577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of spontaneous fabT mutations to a streptococcal toxic shock syndrome to non-streptococcal toxic shock syndrome transition in the novel-type Streptococcus pyogenes isolates that lost a salRK.
    Tatsuno I; Okada R; Matsumoto M; Hata N; Matsui H; Zhang Y; Isaka M; Hasegawa T
    APMIS; 2016 May; 124(5):414-24. PubMed ID: 26861052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
    Sriskandan S; Faulkner L; Hopkins P
    Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial factors in disease emergence illustrated by streptococcal toxic shock syndrome.
    Krause R
    FEMS Immunol Med Microbiol; 1997 Aug; 18(4):227-32. PubMed ID: 9348157
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome.
    Sriskandan S; Moyes D; Cohen J
    Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404
    [No Abstract]   [Full Text] [Related]  

  • 14. Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock.
    Llewelyn M
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S445-8. PubMed ID: 16237645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism behind streptococcus toxic shock-like syndrome onset--immune evasion and bacterial properties].
    Ikebe T; Ato M; Kobayashi K; Watanabe H
    Kansenshogaku Zasshi; 2009 Sep; 83(5):485-9. PubMed ID: 19860247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T serotyping of group a streptococcus isolated from patients with pharyngitis or streptococcal toxic shock syndrome in Japan between 2005 and 2017.
    Ikebe T; Okuno R; Uchitani Y; Kanda Y; Sasaki M; Uchida K; Chiba K; Yamaguchi T; Otsuka H; Suzuki M; Ohya H; Watanabe H; Ohnishi M;
    J Infect Chemother; 2020 Feb; 26(2):157-161. PubMed ID: 31735631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the mysteries of streptococci and their relations with the host.
    Ferrieri P; Horaud T
    Trends Microbiol; 1997 Jan; 5(1):5-7. PubMed ID: 9025228
    [No Abstract]   [Full Text] [Related]  

  • 18. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 19. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
    Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
    Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
    Basma H; Norrby-Teglund A; Guedez Y; McGeer A; Low DE; El-Ahmedy O; Schwartz B; Kotb M
    Infect Immun; 1999 Apr; 67(4):1871-7. PubMed ID: 10085030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.